homemarket NewsNirmal Bang's Rahul Arora bets big on pharma stocks

Nirmal Bang's Rahul Arora bets big on pharma stocks

If Rahul Arora, CEO at Nirmal Bang Institutional Equities makes a portfolio for the next year, pharma, cement, auto and auto ancillaries and banks is where the bulk of his allocation would be, he told CNBC-TV18 while discussing the stocks and the sectors he would bet on.

By Sonia Shenoy   | Nigel D'Souza   | Prashant Nair  Oct 19, 2022 6:21:49 PM IST (Published)

2 Min Read
If Rahul Arora, CEO at Nirmal Bang Institutional Equities, makes a portfolio for the next year, pharma, cement, auto and auto ancillaries and banks are where the bulk of his allocation would be, he told CNBC-TV18 while discussing the stocks and the sectors he would bet on.
“Within that, at least a third to 40 percent of my exposure would be in pharma,” he said adding, "and then the remaining 60 percent would be divided equally amongst other sectors."
Amidst pharma stocks, Arora prefers Sun Pharma and Cipla. “Sun has got a good blend of both US as well as India, so that would be one name that we would definitely play. The other would be Cipla,” he said.